Merck (MRK) Other Working Capital Changes (2009 - 2026)

Merck (MRK) posted quarterly Other Working Capital Changes of $1.6 billion for Q1 2026, down 56.55% YoY from $3.7 billion in Q1 2025, and up 219.48% sequentially from -$1.4 billion in Q4 2025.

Merck (MRK) Other Working Capital Changes (2009 - 2026) Analysis & Trends

Merck has disclosed Other Working Capital Changes across 18 years of filings, most recently posting $1.6 billion for Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 56.55% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 30.81% YoY), while the FY2025 annual figure was $3.3 billion, up 133.55% from the prior year.
  • Other Working Capital Changes grew to $1.6 billion in Q1 2026, from -$1.4 billion in the prior quarter.
  • Over the last five years, Other Working Capital Changes for MRK reached as high as $3.7 billion in Q1 2025 and fell as low as -$2.6 billion in Q3 2024.
  • The 5-year median for Other Working Capital Changes is $1.0 billion (2024), against an average of $595.5 million.
  • Annual changes were most pronounced in 2024 — Other Working Capital Changes plunged 1031.43% — and 2025, when it jumped 123.22%.
  • A 5-year view of Other Working Capital Changes shows it stood at -$962.0 million in 2022, then soared by 96.36% to -$35.0 million in 2023, then sank by 1031.43% to -$396.0 million in 2024, then tumbled by 240.91% to -$1.4 billion in 2025, then surged by 219.48% to $1.6 billion in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered $1.6 billion, -$1.4 billion, and -$1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.61 Bn
Mar 31, 2026 1.61 Bn
Mar 31, 2026 1.61 Bn
Dec 31, 2025 -1.35 Bn
Dec 31, 2025 -1.35 Bn
Dec 31, 2025 -1.35 Bn
Sep 30, 2025 -1.31 Bn
Sep 30, 2025 -1.31 Bn
Sep 30, 2025 -1.31 Bn
Jun 30, 2025 2.26 Bn
Jun 30, 2025 2.26 Bn
Jun 30, 2025 2.26 Bn
Mar 31, 2025 3.71 Bn
Mar 31, 2025 3.71 Bn
Mar 31, 2025 3.71 Bn
Dec 31, 2024 -396.00 Mn
Dec 31, 2024 -396.00 Mn
Dec 31, 2024 -396.00 Mn
Sep 30, 2024 -2.58 Bn
Sep 30, 2024 -2.58 Bn